213 related articles for article (PubMed ID: 20003375)
1. Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.
Tseng YS; Lee JC; Huang CY; Liu HS
BMC Cancer; 2009 Dec; 9():435. PubMed ID: 20003375
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of the differential transformation mediated by Kirsten and Harvey Ras oncogenes in a human colorectal adenocarcinoma cell line.
Roberts ML; Drosopoulos KG; Vasileiou I; Stricker M; Taoufik E; Maercker C; Guialis A; Alexis MN; Pintzas A
Int J Cancer; 2006 Feb; 118(3):616-27. PubMed ID: 16152623
[TBL] [Abstract][Full Text] [Related]
3. Investigating the role of Aurora kinases in RAS signaling.
Kosik A; Bekier ME; Katusin JD; Kaur H; Zhou X; Diakonova M; Chadee DN; Taylor WR
J Cell Biochem; 2009 Jan; 106(1):33-41. PubMed ID: 19009561
[TBL] [Abstract][Full Text] [Related]
4. Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.
Cerrito MG; Galbaugh T; Wang W; Chopp T; Salomon D; Cutler ML
J Cell Physiol; 2004 Nov; 201(2):244-58. PubMed ID: 15334659
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.
Kim IA; Bae SS; Fernandes A; Wu J; Muschel RJ; McKenna WG; Birnbaum MJ; Bernhard EJ
Cancer Res; 2005 Sep; 65(17):7902-10. PubMed ID: 16140961
[TBL] [Abstract][Full Text] [Related]
6. Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development.
Zhang T; Fields JZ; Opdenaker L; Otevrel T; Masuda E; Palazzo JP; Isenberg GA; Goldstein SD; Brand M; Boman BM
Am J Pathol; 2010 Dec; 177(6):2816-26. PubMed ID: 21057000
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
8. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
9. Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
Merchant M; Moffat J; Schaefer G; Chan J; Wang X; Orr C; Cheng J; Hunsaker T; Shao L; Wang SJ; Wagle MC; Lin E; Haverty PM; Shahidi-Latham S; Ngu H; Solon M; Eastham-Anderson J; Koeppen H; Huang SA; Schwarz J; Belvin M; Kirouac D; Junttila MR
PLoS One; 2017; 12(10):e0185862. PubMed ID: 28982154
[TBL] [Abstract][Full Text] [Related]
10. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
11. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.
Drosopoulos KG; Roberts ML; Cermak L; Sasazuki T; Shirasawa S; Andera L; Pintzas A
J Biol Chem; 2005 Jun; 280(24):22856-67. PubMed ID: 15757891
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.
Wang X; Zhou YX; Qiao W; Tominaga Y; Ouchi M; Ouchi T; Deng CX
Oncogene; 2006 Nov; 25(54):7148-58. PubMed ID: 16715125
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1.
Qu Y; Chen Q; Lai X; Zhu C; Chen C; Zhao X; Deng R; Xu M; Yuan H; Wang Y; Yu J; Huang J
Mol Cancer; 2014 Apr; 13():95. PubMed ID: 24775912
[TBL] [Abstract][Full Text] [Related]
14. Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways.
Peyssonnaux C; Provot S; Felder-Schmittbuhl MP; Calothy G; Eychène A
Mol Cell Biol; 2000 Oct; 20(19):7068-79. PubMed ID: 10982823
[TBL] [Abstract][Full Text] [Related]
15. RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects.
Kreeger PK; Mandhana R; Alford SK; Haigis KM; Lauffenburger DA
Cancer Res; 2009 Oct; 69(20):8191-9. PubMed ID: 19789336
[TBL] [Abstract][Full Text] [Related]
16. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
17. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
[TBL] [Abstract][Full Text] [Related]
18. Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer.
Tseng YS; Tzeng CC; Huang CY; Chen PH; Chiu AW; Hsu PY; Huang GC; Wang YC; Liu HS
Cancer Lett; 2006 Sep; 241(1):93-101. PubMed ID: 16338065
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.
van Houdt WJ; de Bruijn MT; Emmink BL; Raats D; Hoogwater FJ; Borel Rinkes IH; Kranenburg O
Cell Oncol; 2010 Jan; 32(4):245-57. PubMed ID: 20413844
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis.
Basu Roy UK; Henkhaus RS; Loupakis F; Cremolini C; Gerner EW; Ignatenko NA
Int J Cancer; 2013 Jul; 133(1):43-57. PubMed ID: 23280667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
